117 related articles for article (PubMed ID: 4113366)
1. [Significance of plasma creatine and neurologic disorders for the creatine level of cerebrospinal fluid in man].
Berlet HH; Pilz H
Z Neurol; 1972; 201(4):310-25. PubMed ID: 4113366
[No Abstract] [Full Text] [Related]
2. Fatty acid changes of cerebrospinal fluid in neurological disorders as an index of changes in the blood-brain barrier.
Pazzagli A; Arnetoli G; Pepeu I; Amaducci LA
Neurology; 1970 Aug; 20(8):783-6. PubMed ID: 5465848
[No Abstract] [Full Text] [Related]
3. [Basic principles and application of cerebrospinal fluid immunoelectrophoresis].
Meyer-Rienecker H
Psychiatr Neurol Med Psychol (Leipz); 1976 Oct; 28(10):577-89. PubMed ID: 798217
[TBL] [Abstract][Full Text] [Related]
4. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
[TBL] [Abstract][Full Text] [Related]
5. Electrophoretic examination of cerebrospinal fluid proteins in multiple sclerosis and other neurological diseases.
Vandvik B; Skrede S
Eur Neurol; 1973; 9(4):224-41. PubMed ID: 4121483
[No Abstract] [Full Text] [Related]
6. Polorography of CSF proteins.
Hanzal F; Brezina M
J Neurol Sci; 1967; 4(2):349-51. PubMed ID: 4166764
[No Abstract] [Full Text] [Related]
7. [Nervous system diseases and proteins in the blood and cerebrospinal fluid].
Ito H; Miura S
Saishin Igaku; 1968 Aug; 23(8):1651-61. PubMed ID: 4883043
[No Abstract] [Full Text] [Related]
8. [Differential electrophoretic analysis of the cerebrospinal fluid in acrylamide gel in allergic-inflammatory and degenerative diseases of the central nervous system].
Gandini S; Rossi R
Acta Neurol (Napoli); 1970; 25(2):176-81. PubMed ID: 5422842
[No Abstract] [Full Text] [Related]
9. [The so-called paralysis curve of the goldsol reaction in nonsyphiliic neuropathies].
Grahmann H
Nervenarzt; 1969 Feb; 40(2):92-5. PubMed ID: 4312052
[No Abstract] [Full Text] [Related]
10. Cerebrospinal fluid electrolyte disturbances in neurological disorders: with special reference to inorganic phosphate.
Breyer U; Kanig K
Neurology; 1970 Mar; 20(3):247-53. PubMed ID: 5461053
[No Abstract] [Full Text] [Related]
11. [Leukotrienes and neurological diseases].
Irkeç C; Ercan S; Irkeç M
Mikrobiyol Bul; 1989 Oct; 23(4):342-7. PubMed ID: 2488942
[TBL] [Abstract][Full Text] [Related]
12. [On the role of enteric viruses in the pathology of the nervous system].
Modestova NV; Matveeva MV; Manelis ZS; Grebneva NS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(2):176-80. PubMed ID: 4298317
[No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid and serum light polypeptide chains in 160 patients with various nervous system disorders.
Kolar O; Anthony E
Z Neurol; 1971; 200(1):6-17. PubMed ID: 4107209
[No Abstract] [Full Text] [Related]
14. Diagnostic significance of cereborspinal-fluid examinations in myelopathy.
Gårde A; Kjellin KG
Acta Neurol Scand; 1971; 47(5):555-68. PubMed ID: 4110749
[No Abstract] [Full Text] [Related]
15. The CSF iron in patients with neurological diseases.
Kjellin KG
Acta Neurol Scand; 1967; 43(3):299-313. PubMed ID: 4227818
[No Abstract] [Full Text] [Related]
16. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
[TBL] [Abstract][Full Text] [Related]
17. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.
Meyne F; Gloeckner SF; Ciesielczyk B; Heinemann U; Krasnianski A; Meissner B; Zerr I
J Alzheimers Dis; 2009; 17(4):863-73. PubMed ID: 19542614
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive IFN-gamma in CSF in neurological disorders.
Abbott RJ; Bolderson I; Gruer PJ; Peatfield RC
J Neurol Neurosurg Psychiatry; 1987 Jul; 50(7):882-5. PubMed ID: 3114431
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.
Ziegler MG; Brooks BR; Lake CR; Wood JH; Enna SJ
Neurology; 1980 Jan; 30(1):98-101. PubMed ID: 7188643
[TBL] [Abstract][Full Text] [Related]
20. Study of serum and cerebrospinal fluid ceruloplasmin in multiple sclerosis and other neurologic diseases.
Becuş T; Popoviciu L; Palade C
Rev Roum Neurol; 1971; 8(1):3-13. PubMed ID: 5563146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
